Marsh & McLennan Companies, Inc.
MRSH Financial Services Insurance - Brokers NYSE
$186.74
+$1.45 (+0.78%)
Open: $185.45 | High: $187.69 | Low: $184.68 | Prev Close: $185.29
Market Cap: $91.49B
Volume: 2.0M | Avg: 3.0M
Last updated: March 02, 2026 at 08:03 AMInvestment Rating
Neutral
Overall Score: 60/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 534
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 22.18 |
| P/B Ratio | 6.02 |
| P/S Ratio | 3.39 |
| EPS | $8.42 |
| Beta | 0.74 |
| Shares Outstanding | 489.91M |
| 52-Week High | $248.00 |
| 52-Week Low | $170.37 |
| SMA 50 | $182.92 |
| SMA 200 | $198.14 |
| Dividend Yield | 1.88% |
| Annual Dividend | $3.52 |
| Next Earnings | April 16, 2026 01:30 PM ET |
Financial Ratios
| Gross Margin | 42.3% |
| Operating Margin | 23.1% |
| Net Margin | 15.4% |
| ROE | 27.7% |
| ROA | 7.1% |
| Debt/Equity | 1.42 |
| Current Ratio | 1.10 |
| Quick Ratio | 1.10 |
Balance Sheet
| Total Assets | $58.71B |
| Total Liabilities | $43.40B |
| Total Equity | $15.10B |
|
|
|
| Cash | $2.69B |
| Total Debt | $21.45B |
| Net Debt | $18.76B |
Income Statement
| Revenue | $26.98B |
| Gross Profit | $11.40B |
| Operating Income | $6.22B |
| Net Income | $4.16B |
|
|
|
| EBITDA | $7.39B |
| Revenue/Share | $55.40 |
Cash Flow
| Operating CF | $5.29B |
| CapEx | $291.00M |
| Free Cash Flow | $5.00B |
|
|
|
| Book Value/Share | $31.45 |
| Tangible Book/Share | $-28.27 |
| Equity/Share | $31.01 |
Technical Indicators
| RSI (14) | 50.00 Neutral |
| MACD |
0.00
Signal: 0.00
|
| Volatility | 0.00% |
| Trading Signal | Neutral |
Performance & Returns
Insufficient historical data
Insufficient historical data (need 200+ days, have 9)Sector Comparison (Financial Services)
| Metric | MRSH | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 22.18 | 47.83 | 57% |
| P/B Ratio | 6.02 | 4.14 | 83% |
| ROE (%) | 27.69% | 19.59% | 83% |
| Net Margin (%) | 15.42% | 18.79% | 40% |
| Stock Score | 534 | 429.0 | 73% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSH | $186.74 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 50.00 | 0.00 | 0.00% | 0 | Neutral | Mixed |
Candlestick Patterns
There wasn't any recognizable pattern for the MRSH stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| MRSH | Marsh & McLennan Companies, Inc. $MRSH Shares Sold by Ameriprise Financial Inc. | Positive | defenseworld.net | Read More |
| MRSH | Brown Brothers Harriman & Co. Grows Stake in Marsh & McLennan Companies, Inc. $MRSH | Neutral | defenseworld.net | Read More |
| MRSH | Marsh & McLennan Companies, Inc. $MRSH Shares Purchased by Brown Brothers Harriman & Co. | Neutral | defenseworld.net | Read More |
| MRSH | FORA Capital LLC Acquires 9,693 Shares of Marsh & McLennan Companies, Inc. $MRSH | Neutral | defenseworld.net | Read More |
| MRSH | FORA Capital LLC Has $2.31 Million Stock Position in Marsh & McLennan Companies, Inc. $MRSH | Neutral | defenseworld.net | Read More |
Recent Insider Trading
No recent insider trading data available for MRSH
Company Information
Marsh & McLennan Cos., Inc. is a professional services firm, which offers clients advice and solutions in risk, strategy and people. The company is headquartered in New York, New York and currently employs 65,000 full-time employees. The firm is the parent company of various risk advisors and specialty consultants, including Marsh, the insurance broker; Guy Carpenter, the risk and reinsurance specialist; Mercer, the provider of human resource and investment related financial advice and services, and Oliver Wyman Group, the management and economic consultancy. The company conducts business through two segments: Risk and Insurance Services, which includes risk management activities, as well as insurance and reinsurance broking and services, and Consulting includes health, retirement, talent and investments consulting services and products, and specialized management, economic and brand consulting services. The company conducts business in the Risk and Insurance Services segment through Marsh and Guy Carpenter. The company conducts business in the Consulting segment through Mercer and Oliver Wyman Group.
| CEO | John Quinlan Doyle |
| Employees | 90000 |
| Country | US |
| IPO Date | 1987-12-30 |
| Exchange | NYSE |
| Website | https://www.marsh.com |
| Sector | Financial Services |
| Industry | Insurance - Brokers |
Similar Stocks (Financial Services - Insurance - Brokers)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category